Peter Carlson

PGY2 in Pediatrics at Seattle Children's Hospital, interested in cancer immunotherapy and pediatric oncology. Alum of @UWMSTP in Wisconsin

[Society for Immunotherapy of Cancer @sitcancer]

SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH & the new administration to reverse this action to ensure life-saving cancer treatments continue to reach the clinic and patients. https://t.co/eqLJOoBDIP

[Peter Carlson @PeterCarlsonMD]

@KimpleRandall @UW_RadoncDHO @UWMadison Congratulations! Very well deserved!!!

[Peter Carlson @PeterCarlsonMD]

Excited to share my work with @ZachMorrisMDPhD and @RPatelMDPHD showing that we can use low-dose systemic molecular targeted radionuclide therapy to enhance immune responses to local solid tumor vaccines!

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination https://t.co/TEJU0wcVrQ @PeterCarlsonMD @PiepsTweeets

[Emily Kemper, MD @DrEmilyKemper]

Please.

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Short-course neoadjuvant in situ vaccination for murine melanoma https://t.co/QT10XjnUIy

[UW MSTP (University of Wisconsin-Madison) @UWMSTP]

#PubAlert #TeamScience! MSTP students & alums: M4 @PiepsTweeets G4 @JJagodinsky & MSTP alum @PeterCarlsonMD published in @FrontImmunol
Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in I… https://t.co/Wek80kc0Xg

[Ravi Patel @RPatelMDPHD]

Excited to share our new publication which shows that low dose radiopharmaceutical therapy can enhance efficacy of immune checkpoint blockade in “cold” tumors. @ZachMorrisMDPhD @artlab_wisc @JosephGrudzins1 @UPMCHillmanCC @UWCarbone @IOTNmoonshot https://t.co/XTcMJamuPH

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors @murtaza_ahm https://t.co/IRN1KjhhNJ

[University of Wisconsin Department of Pediatrics @WiscPediatrics]

Four @uwsmph researchers have received prestigious awards from the @ACTScience, including one of @WiscPediatrics very own, Dr. Paul Sondel. More on this award ⬇️: https://t.co/ogGyyOJNku

[University of Wisconsin Department of Pediatrics @WiscPediatrics]

Dr. Anna Huttenlocher was recently awarded a two-year grant from @NIH-@niaid for her project, “Imaging Immunometabolism in live animals during host defense.”
More on the aims of this study ⬇️: https://t.co/V80DzfhRWv

[Peter Carlson @PeterCarlsonMD]

Very happy to see our new publication up now on @jitcancer - a simple and effective means of improving variability in implanted mouse tumor models for immunotherapy - depth makes a big difference! Thank you to @RPatelMDPHD @ZachMorrisMDPhD @matrodmed

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model https://t.co/OS0J2kYwjC

[UW MSTP (University of Wisconsin-Madison) @UWMSTP]

Congratulations again- so proud of you all!! <3 your MSTP! #MatchDay2021 @uwsmph #doubledocs
@PeterCarlsonMD @Cenilicus @AmeliaHaj @JackFVHunt @jrodriguezgil @lcswanson2 @kkrautie

[University of Wisconsin Department of Pediatrics @WiscPediatrics]

Drs Capitini, DeSantes, Erbe-Gurel, Hank, Huttenlocher, Otto, Rakhmilevich, Sondel and @UWCarbone researchers were recently recognized w/ the @sitcancer Team Science Award for their long-standing contribution to the field of cancer immunotherapy. More: https://t.co/fABIaF9ql5

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Identification of neuroblastoma cell lines with uncommon TAZ+/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells https://t.co/3OZ4tlOr9u